Skip to content

Thyroid Cancer Nonmedullary 3 C4225410

Published: July 22, 2026Updated: August 20, 2026

A form of thyroid cancer that develops from follicular cells. Treatment typically includes surgery and may involve radioactive iodine or other therapies depending on cancer characteristics.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Thyroid enlargement

!

Persistent cough

!

Voice changes

!

Lymphadenopathy

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Total thyroidectomy with lymph node dissection

Complete thyroid removal with therapeutic central or lateral neck compartment lymph node dissection is performed for more advanced nonmedullary thyroid cancers. This ensures complete tumor clearance and accurate staging.

surgical
3

Radioactive iodine therapy

Adjuvant radioactive iodine ablation is routinely recommended for stage III thyroid cancer to eliminate residual thyroid tissue and any microscopic metastatic disease. Higher activities may be used compared to lower-risk disease.

procedure

Additional treatment options

Intensive TSH suppression

High-degree TSH suppression with levothyroxine is achieved for higher-risk thyroid cancer to minimize stimulation of any residual cancer cells. Target TSH levels are typically maintained below 0.1 mIU/L.

medication

External beam radiation therapy

External beam radiation may be considered for local control in cases with residual unresectable disease, incomplete surgical margins, or high-risk extrathyroidal extension.

procedure

Cancer survivorship support

Psychological support and survivorship programs help patients cope with cancer diagnosis, treatment side effects, and long-term follow-up concerns. Support groups specifically for thyroid cancer survivors can provide valuable peer support.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Thyroid Cancer Nonmedullary 3 C4225410?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016.

guideline2016View source →
2

Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016.

review2016View source →
3

Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus placebo in radioiodine-refractory differentiated thyroid cancer. N Engl J Med. 2015.

clinical_trial2015View source →
4

Brose MS, Nutting CM, Jarzab B, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014.

meta_analysis2014View source →

Medication Comparisons

Compare medications used to treat Thyroid Cancer Nonmedullary 3 C4225410. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy